Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis (Q73792951)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

cytomegalovirus retinitis

6 November 2019

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

J C Macdonald

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M P Karavellas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F J Torriani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

I L Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J B Reed

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

W R Freeman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

877-81; discussion 881-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Opportunistic infections occurring during highly active antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Cli

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

HIV treatment failure: testing for HIV resistance in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

Clinical versus fundus photographic evaluation of the status of cytomegalovirus retinitis in AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900023-3

7 January 2021

10.1016/S0161-6420(00)00023-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811078%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference